Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Clinical Nutrition

• Publication date

  2006-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/AJCN/84.3.556PMID 16960169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system.

  2005cited by this paper
• Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects.

  2005cited by this paper
• Neural regulation of glucagon-like peptide-1 secretion in pigs.

  2004cited by this paper
• Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.

  2004cited by this paper
• Variability in energy expenditure and its components

  2004cited by this paper
• Glucagon-like peptide-1 and glucagon-like peptide-2

  2004cited by this paper
• The potential role of glucagon-like peptide 1 in diabetes.

  2004cited by this paper
• Fate of fatty acids at rest and during exercise: regulatory mechanisms.

  2003cited by this paper
• Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

  2003cited by this paper
• Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites

  2003cited by this paper
• The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

  2001cited by this paper
• Minireview: the glucagon-like peptides.

  2001cited by this paper
• Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

  2000cited by this paper
• Differential brain responses to satiation in obese and lean men.

  2000cited by this paper
• The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans

  2000cited by this paper
• Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes.

  1999cited by this paper
• Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography.

  1999cited by this paper
• Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects

  1999cited by this paper
• Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.

  1998cited by this paper
• Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.

  1998cited by this paper
• Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

  1998cited by this paper
• Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.

  1998cited by this paper
• The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.

  1997cited by this paper
• Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

  1997cited by this paper
• Effects of glucagon‐like peptide 1 (7–36 amide) on whole‐body protein metabolism in healthy man

  1997influential reference
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• The sympathetic nervous system as a target for intervention in obesity.

  1995cited by this paper
• Familial dependence of the resting metabolic rate.

  1986cited by this paper
• Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber.

  1986cited by this paper
• Familial dependence of the resting metabolic rate.

  1986cited by this paper
• Energy expenditure before and during energy restriction in obese patients.

  1985cited by this paper
• Vagal, cholinergic regulation of pancreatic polypeptide secretion.

  1978cited by this paper

• Incretins and the cardiovascular system: bridging digestion with metabolism.

  2025cites this paper
• Mediterranean Diet Patterns Are Positively Associated with Maximal Fat Oxidation and VO2max in Young Adults: The Mediating Role of Leptin

  2025cites this paper
• Impaired metabolic flexibility to fasting is associated with increased ad libitum energy intake in healthy adults

  2024cites this paper
• Postprandial energy metabolism is modulated in response to a low-intensity walking exercise in fasted healthy individuals.

  2024cites this paper
• Consumption of probiotic yogurt and vitamin D‐fortified yogurt increases fasting level of GLP‐1 in obese adults undergoing low‐calorie diet: A double‐blind randomized controlled trial

  2022cites this paper
• The association between gut hormones and diet‐induced metabolic flexibility in metabolically healthy adults

  2022cites this paper
• Acetate Does Not Affect Palmitate Oxidation and AMPK Phosphorylation in Human Primary Skeletal Muscle Cells

  2021cites this paper
• Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes

  2021cites this paper
• Relationships between diet and basal fat oxidation and maximal fat oxidation during exercise in sedentary adults.

  2020cites this paper
• The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial

  2020cites this paper
• Response to comments on “The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed methods study”

  2020cites this paper
• Relationship between inflammation and metabolic regulation of energy expenditure by GLP-1 in critically ill children.

  2020cites this paper
• Probiotic and Lifestyle Modification in Obese Pediatrics with Non-Alcoholic Fatty Liver Disease

  2019cites this paper
• Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists

  2019cites this paper
• The relationship between enteral nutrition, energy metabolism and gut homeostasis during the course of critical illness

  2019cites this paper
• Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.

  2019cites this paper
• Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids.

  2018cites this paper
• Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.

  2018cites this paper
• Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors

  2018cites this paper
• The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial

  2018cites this paper
• Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits

  2018cites this paper
• Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential

  2018cites this paper
• Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults?

  2018cites this paper
• Differential increments of basal glucagon‐like‐1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter‐individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes

  2017cites this paper
• Novel biomarkers associated with gestational diabetes mellitus and metabolic outcomes of pregnancy

  2017cites this paper
• Prediabetes in youth – mechanisms and biomarkers

  2017cites this paper
• Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

  2016cites this paper
• Metabolomic profiling reveals differential effects of glucagon-like peptide-1 and insulin on nutrient partitioning in ovine liver.

  2016cites this paper
• Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals

  2016cites this paper
• Comparison of Plasma Active Glucagon-Like Peptide 1 Concentrations in Normal Horses and Those With Equine Metabolic Syndrome and in Horses Placed on a High-Grain Diet

  2016cites this paper
• Influence of cyclic changes in ovarian hormones on resting metabolic rate and appetite in women

  2016cites this paper
• Neurodegeneration as an early event in the pathogenesis of diabetic retinopathy: therapeutic implications /

  2016cites this paper
• Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease.

  2016cites this paper
• Cooking enhances beneficial effects of pea seed coat consumption on glucose tolerance, incretin, and pancreatic hormones in high-fat-diet-fed rats.

  2015cites this paper
• Differential Patterns and Determinants of Cardiac Autonomic Nerve Dysfunction during Endotoxemia and Oral Fat Load in Humans

  2015cites this paper
• Multi-omics of obesity and weight change in the post-genomic era

  2015cites this paper
• Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor

  2015cites this paper
• Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice

  2015cites this paper
• Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity.

  2015cites this paper
• Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention

  2015cites this paper
• Plasma levels of glucagon‐like peptide 1 and markers of obesity among young and healthy adults

  2015cites this paper
• Treatment of obesity: bariatric surgery

  2015cites this paper
• Klinische Bedeutung von Begleiterkrankungen der chronischen Herzinsuffizienz

  2014cites this paper
• Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists

  2014cites this paper
• The influence of calcium supplementation on substrate metabolism during exercise in humans: a randomized controlled trial

  2014cites this paper
• From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis?

  2014cites this paper
• At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.

  2014cites this paper
• Comparative analysis of plasma metabolomics response to metabolic challenge tests in healthy subjects and influence of the FTO obesity risk allele

  2014cites this paper
• Thermogenic changes after gastric bypass, adjustable gastric banding or diet alone.

  2014cites this paper
• Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities.

  2014cites this paper
• The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications

  2014cites this paper
• The physiological effects of resistant starch on obesity and diabetes

  2014cites this paper
• The effect of liraglutide on microvascular complications and cardiovascular risk in patients with type 2 diabetes

  2014cites this paper
• Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).

  2013cites this paper
• Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion*

  2013cites this paper
• Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.

  2013cites this paper
• Glucagon‐Like Peptide‐1 Receptor in the Brain: Role in Neuroendocrine Control of Energy Metabolism and Treatment Target for Obesity

  2013cites this paper
• Surgical Weight Loss: Impact on Energy Expenditure

  2013cites this paper
• Metabolic Effects of Bariatric Surgery: A Focus on Inflammation and Diabetic Kidney Disease

  2013cites this paper
• Lipid Metabolic Alterations and Satiety with a Pumpkin-Based supplement in Obese Dogs

  2013cites this paper
• Glucagon-Like Peptide-1 Secretory Function as an Independent Determinant of Blood Pressure: Analysis in the Tanno-Sobetsu Study

  2013cites this paper
• High-Amylose Resistant Starch Increases Hormones and Improves Structure and Function of the Gastrointestinal Tract: A Microarray Study

  2012cites this paper
• Alterations in energy balance following exenatide administration.

  2012cites this paper
• Novel GLP-1 receptor agonists for diabetes

  2012cites this paper
• Traditional Ethnic Diets, Genetic Pre-Susceptibility and Gene-Diet Interaction Associations with Type 2 Diabetes and Risk Factors

  2012cites this paper
• Mechanisms by Which Resistant Starch Produces Gut Hormones and Reduces Body Fat

  2012cites this paper
• Peripheral signalling involved in energy homeostasis control

  2012cites this paper
• Effects of 6-Month Sitagliptin Treatment on Glucose and Lipid Metabolism, Blood Pressure, Body Weight and Renal Function in Type 2 Diabetic Patients: A Chart-Based Analysis

  2012cites this paper
• Dietary Whey Protein Decreases Food Intake and Body Fat in Rats

  2011influential citation
• Predicting response to incretin-based therapy

  2011cites this paper
• Is the GLP-1 system a viable therapeutic target for weight reduction?

  2011cites this paper
• JTT‐130, a novel intestine‐specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet‐induced obesity and glucose intolerance in Sprague‐Dawley rats

  2011cites this paper
• Dietary Fiber/Carnitine, Diacylglycerol, and Low Glycemic Index Starch Effects on Obesity and Triglyceride Rich Lipoprotein Metabolsim in Dogs

  2011cites this paper
• Lower Gut Hormones and Health Effects Associated with Consumption of Fermentable Fibers

  2011cites this paper
• Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.

  2011cites this paper
• Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity

  2010cites this paper
• Diagnosis and Management of Horses with Equine Metabolic Syndrome (EMS)

  2010cites this paper
• Review article Exenatide and weight loss

  2010cites this paper
• Thermoregulation, energy balance, regulatory peptides: recent developments.

  2010cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2010cites this paper
• Exenatide and weight loss.

  2010cites this paper
• Emerging role of GLP-1 receptor agonists in the treatment of obesity

  2010cites this paper
• Resistant starch and sodium butyrate reduce body fat in rodents

  2010cites this paper
• Treatment with Sitagliptin or Metformin Does Not Increase Body Weight despite Predicted Reductions in Urinary Glucose Excretion

  2009cites this paper
• Eyes are bigger than the stomach: Correlation between body mass index, satiety, and prediction of satiety

  2009cites this paper
• Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.

  2008cites this paper
• Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice

  2008cites this paper
• Glucose Tolerance, Lipids, and GLP‐1 Secretion in JCR:LA‐cp Rats Fed a High Protein Fiber Diet

  2008cites this paper
• Association of β2-adrenergic receptor and insulin receptor substrate-1 polymorphisms with obesity in a Northern Indian population

  2008cites this paper
• An overview of pediatric obesity

  2007cites this paper
• The 24-h carbohydrate oxidation rate in a human respiratory chamber predicts ad libitum food intake.

  2007cites this paper